source
- Jasper Therapeutics secures $132 million and merges with Kira Pharmaceuticals to revive pipelineJasper Therapeutics, a cash‑strapped biotech, announced it completed an all‑stock acquisition of privately held immune‑drug developer Kira Pharmaceuticals. The merger is paired with a private stoc…
- GSK to launch large trial testing shingles vaccine’s potential to reduce Alzheimer’s riskGSK announced it will conduct a large-scale clinical study to evaluate whether the shingles vaccine can lower the risk of developing Alzheimer’s disease. The move follows observations from analyses…